Production (Stage)
ORIC Pharmaceuticals, Inc.
ORIC
$9.32
$0.161.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.03% | -28.16% | -35.67% | -39.31% | -4.45% |
| Total Depreciation and Amortization | 15.71% | 15.59% | 5.06% | 5.02% | 3.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.69% | 96.86% | 60.14% | 5.02% | -0.80% |
| Change in Net Operating Assets | -3.91% | 120.77% | -34.26% | 426.48% | -2,726.05% |
| Cash from Operations | -7.78% | -15.59% | -46.59% | -21.19% | -46.34% |
| Capital Expenditure | -77.52% | -284.21% | -442.86% | 17.78% | 29.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.04% | 103.97% | 140.67% | 198.44% | -571.04% |
| Cash from Investing | 136.29% | 103.48% | 139.89% | 194.65% | -584.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.80% | 26.65% | 306.45% | -99.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -44.05% | 100.00% | -- | 100.00% | -- |
| Cash from Financing | -99.99% | 26.93% | 306.45% | -99.04% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.54% | 631.74% | 92.77% | -114.60% | 520.08% |